Kenny Otillio

Seventeen years of experience cultivating relationships in south Louisiana with medical oncologist, advanced practitioners and office staff. Drive sales of Velcade and Ninlaro for multiple myeloma by assessing physician/patient needs, providing relevant product knowledge, and implementing strategy. Partnered with Market Access to educate accounts on patient reimbursement optimizations. Cross functional collaboration throughout the oncology business unit. Developed KOL relationships to promote Velcade/Ninlaro and educate the medical community.

Selected Accomplishments:

• Regional Trainer
• Field Advisory Board
• West Area Culture Team
• Ranked #1 in my region (2008, 2014, 2015, 2017)
• National rankings

2011/18, 2012/30, 2013/39, 2014/18, 2015/9, 2018/31

• Millennium/Takeda Cup 2015
• Takeda Cup FY2022 Ranked #1

Commercialize and launch of (PRIALT) an injectable biological for severe chronic pain. Consultative selling in "buy and bill" model to neurosurgeons, hospitals, and interventional pain specialists. **(Left do to possible divesture of PRIALT)**

Commercialize and launch of (PLENAXIS) an injectable suspension to urologist and oncologist for advanced symptomatic prostate cancer in a "buy and bill" model. **(Stopped commercialization of PLENAXIS)**

* First quarter 2004 #1 in company sales

Labcorp-Acquired Dianon Systems and Urocor in January 2003-markets a comprehensive range of integrated products and services to assist physicians in detecting, diagnosing, treating and monitoring cancer patients. Our primary focus was selling to oncologist, urologist, dermatologist, gastroenterologist, and infectious disease. For two years Urocor co-marketed with Astra/Zeneca Pharmaceutical (Zoladex and Casodax drugs for advanced prostate cancer), as well as marketing Brachytherapy seeds-(Prostate radioactive seed implantation) and PACIS (BCG) intravesical therapy for bladder cancer.

Accomplishments: Averaged over 37% growth/yr for 7 yrs

* 2002 sales $2,570,000 28% growth (realigned at 2 million)

* 2001 sales $5,200,000 33% growth

* 2000 sales $3,900,000 53% growth

* 1999 sales $2,545,000 27% growth

* 1998 sales $2,000,000 48% growth

* 1997 sales $1,345,000 34% growth

* 1996 sales $1,000,000 43% growth

* 1995 sales $700,000

Responsible for the sales of a broad line of products in Southern Louisiana including: Monject Needles & Syringes, Dover Urologicals, Blood Collection products and U.S. Clinical-Chemotherapy products

* 4th/69 reps in sales (safety syringes)

* 8th/69 reps in sales (silicone catheters)

Primary sales of medical surgery supplies and capital equipment to surgery centers, physician offices, clinics and home health agencies. Distribution for companies such as: Johnson & Johnson, Kendall, Ritter Midmark

Responsibilities included the marketing of claims services to insurance companies and law firms in the Louisiana territory.